Skip to main content
. Author manuscript; available in PMC: 2019 Feb 1.
Published in final edited form as: Laryngoscope. 2017 Sep 20;128(2):E59–E67. doi: 10.1002/lary.26893

Fig. 3.

Fig. 3

DON reduces soluble collagen production in iLTS fibroblasts. In (A), soluble collagen production is reported on a per-subject basis. Soluble collagen production by iLTS scar fibroblasts is significantly greater than normal fibroblasts. Treatment with DON significantly reduces collagen production of iLTS scar fibroblasts. Rates of soluble collagen production by DON-treated iLTS scar fibroblasts and normal fibroblasts are not significantly different. (B) An averaged view of the individual results.

DON = 6-diazo-5-oxo-l-norleucine; iLTS = iatrogenic laryngotracheal stenosis.